ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

17.69
Delayed Data
As of May 25
 +0.22 / +1.26%
Today’s Change
14.51
Today|||52-Week Range
41.20
-41.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.4B

Company Description

ACADIA Pharmaceuticals, Inc. engages in the research, development and manufacture of pharmaceutical products. It focuses on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Contact Information

ACADIA Pharmaceuticals, Inc.
3611 Valley Centre Drive
San Diego California 92130-3331
P:(858) 558-2871
Investor Relations:

Employees

Shareholders

Mutual fund holders55.70%
Other institutional43.46%
Individual stakeholders29.81%

Top Executives

Stephen R. DavisPresident, Chief Executive Officer & Director
Bob MischlerSenior VP-Strategy & Technology Operations
Todd S. YoungExecutive VP, Chief Financial & Accounting Officer
Srdjan R. StankovicExecutive VP, Head-Research & Development
James OwenChief Medical Officer & SVP-Clinical Development